Session Type: ACR Poster Session C
Session Time: 9:00AM-11:00AM
To study the prevalence and risk factors for serious infections (SIs) in rheumatoid arthritis (RA) patients receiving the
Patients with RA included in the Hong Kong Biologics Registry since 2007 ever treated with b/
2355 courses of b/
Conclusion: SIs causing withdrawal of b/tsDMARDs in patients with RA account for one-third of all SAEs. Increasing age, male sex and concomitant chronic chest conditions were independent risk factors for SIs. Infliximab was associated with the highest rates of serious TB and non-TB infection, and this observation was consistent in all quintiles of patients with different propensity to SIs.
To cite this abstract in AMA style:Mok CC, Wan TH, Fong LS. Prevalence and Risk Factors of Serious Infections in Rheumatoid Arthritis Patients Receiving the Biologic/Targeted Synthetic Dmards: A Propensity Score Analysis from the Hong Kong Biologics Registry [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/prevalence-and-risk-factors-of-serious-infections-in-rheumatoid-arthritis-patients-receiving-the-biologic-targeted-synthetic-dmards-a-propensity-score-analysis-from-the-hong-kong-biologics-registry/. Accessed May 16, 2021.
« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-risk-factors-of-serious-infections-in-rheumatoid-arthritis-patients-receiving-the-biologic-targeted-synthetic-dmards-a-propensity-score-analysis-from-the-hong-kong-biologics-registry/